Built-In Orchestrated Analytics Function Enables Faster and Smarter
Decision-Making
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--
IQVIA™
(NYSE: IQV) today announced the expansion of Orchestrated
Customer Engagement (OCE), IQVIA
Technologies’ innovative commercial ecosystem, with the addition of
Orchestrated Analytics for OCE, a powerful and flexible analytics
solution that empowers life sciences companies to make smarter decisions
by providing increased access to insights.
Orchestrated Analytics addresses many industry challenges, such as
gaining actionable insights from relevant and consistent key performance
indicators (KPI) and benchmarks, establishing best practices, managing
the volume and variety of information, and handling increased resource
constraints. With a pre-configured industry-specific KPI library, guided
analytics for diverse user groups, and end-to-end use in departmental or
enterprise solutions, Orchestrated Analytics is a long-term solution
that supports companies as their needs grow and change.
“Life sciences sales professionals face multiple challenges in creating
meaningful interactions with their healthcare provider customers, from
stricter access to providers to lack of visibility into communications
with other channels in their own organizations,” said Mike Townsend,
research director for Life Sciences Commercial Strategies at IDC Health
Insights. “The use of advanced analytics within the commercial software
ecosystem, that they use daily, will help deliver insights to prioritize
the most important actions they can take in real time, maximizing their
productivity and effectiveness while eliminating duplicate or confusing
messages for their busy HCP customers.”
With access to multiple data sources managed through a flexible
platform, Orchestrated Analytics allows a broader set of people across
the enterprise to derive focused insights relevant to their role. It
provides a unique and intuitive early warning system that identifies
areas of potential growth or risk to accelerate and improve the quality
of decision-making.
“This integrated analytics solution surpasses the capability available
in the market today, and provides a step change to our life sciences
customers, who need every competitive advantage possible,” said Tal
Rosenberg, senior vice president, Global Technology Solutions for IQVIA
Technologies. “We are proud to announce this important next step in our
ongoing expansion of the orchestrated commercial ecosystem. The addition
of Orchestrated Analytics delivers on our promise to customers to
continually develop transformative technologies.”
Launched in December 2017, the OCE platform connects sales, marketing,
medical and other functions to help life sciences companies move to a
new orchestrated commercial model that improves organizational
promotional alignment and as a result, customer experience and trust.
Orchestrated Analytics seamlessly integrates with the other components
of the ecosystem, and is designed to evolve with adaptable dashboards,
allowing for easy expansion and continuous innovation.
About IQVIA
IQVIA (NYSE: IQV) is a leading global provider of advanced analytics,
technology solutions and contract research services to the life sciences
industry. Formed through the merger of IMS Health and Quintiles, IQVIA
applies human data science — leveraging the analytic rigor and clarity
of data science to the ever-expanding scope of human science — to enable
companies to reimagine and develop new approaches to clinical
development and commercialization, speed innovation and accelerate
improvements in healthcare outcomes. Powered by the IQVIA CORE™, IQVIA
delivers unique and actionable insights at the intersection of
large-scale analytics, transformative technology and extensive domain
expertise, as well as execution capabilities. With more than 58,000
employees, IQVIA conducts operations in more than 100 countries.
IQVIA is a global leader in protecting individual patient privacy. The
company uses a wide variety of privacy-enhancing technologies and
safeguards to protect individual privacy while generating and analyzing
information on a scale that helps healthcare stakeholders identify
disease patterns and correlate with the precise treatment path and
therapy needed for better outcomes. IQVIA’s insights and execution
capabilities help biotech, medical device and pharmaceutical companies,
medical researchers, government agencies, payers and other healthcare
stakeholders tap into a deeper understanding of diseases, human
behaviors and scientific advances, in an effort to advance their path
toward cures. To learn more, visit www.iqvia.com.
IQVIAFIN
Click
here to subscribe to Mobile Alerts for IQVIA.
View source version on businesswire.com:
https://www.businesswire.com/news/home/20190409005580/en/
Tor Constantino
IQVIA Media Relations
tor.constantino@iqvia.com
+1.484.567.6732
Andrew Markwick
IQVIA Investor Relations
andrew.markwick@iqvia.com
+1.973.257.7144
Source: IQVIA